Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition-related update and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T11:12:58.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T11:56:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:18.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error instead of the study details, indicating restricted access to the record. This blocks viewing the study information on the NCT02718066 page.
    Difference
    21%
    Check dated 2026-09-21T20:05:15.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor, non-user-facing update.
    Difference
    0.1%
    Check dated 2026-08-31T17:57:09.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.6.5 instead of Revision: v3.6.4. This reflects a minor revision update to the page template or CMS, with no changes to the study content.
    Difference
    0.0%
    Check dated 2026-08-10T12:53:49.000Z thumbnail image

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.